BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37421206)

  • 21. Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
    Short SC; Giampieri S; Worku M; Alcaide-German M; Sioftanos G; Bourne S; Lio KI; Shaked-Rabi M; Martindale C
    Neuro Oncol; 2011 May; 13(5):487-99. PubMed ID: 21363882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the implications of cyclin D1 in melanomas.
    González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
    Smalley KS; Lioni M; Dalla Palma M; Xiao M; Desai B; Egyhazi S; Hansson J; Wu H; King AJ; Van Belle P; Elder DE; Flaherty KT; Herlyn M; Nathanson KL
    Mol Cancer Ther; 2008 Sep; 7(9):2876-83. PubMed ID: 18790768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced DNA damage and altered expression of p21, cyclin D1 and Mre11 genes in human fibroblast cell lines with different radiosensitivity.
    Bahreyni-Toossi MT; Azimian H; Aghaee-Bakhtiari SH; Mahmoudi M; Sadat-Darbandi M; Zafari N
    Mutat Res; 2021; 823():111760. PubMed ID: 34390933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer.
    Yao G; Tang J; Yang X; Zhao Y; Zhou R; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S
    Theranostics; 2020; 10(24):11144-11158. PubMed ID: 33042275
    [No Abstract]   [Full Text] [Related]  

  • 27. Integrin αvβ3-Akt signalling plays a role in radioresistance of melanoma.
    Im H; Lee J; Ryu KY; Yi JY
    Exp Dermatol; 2020 Jun; 29(6):562-569. PubMed ID: 32298492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle.
    Shimura T
    J Radiat Res; 2011; 52(5):539-44. PubMed ID: 21881296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation.
    Choi C; Park S; Cho WK; Choi DH
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21.
    Bélanger F; Roussel C; Sawchyn C; St-Hilaire E; Gezzar-Dandashi S; Kimenyi Ishimwe AB; Mallette FA; Wurtele H; Drobetsky E
    J Biol Chem; 2023 Jul; 299(7):104900. PubMed ID: 37301510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD81 Enhances Radioresistance of Glioblastoma by Promoting Nuclear Translocation of Rad51.
    Zheng W; Chen Q; Liu H; Hu S; Zhou Y; Bai Y; Zhang J; Pan Y; Shao C
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells.
    Peng G; Cao RB; Li YH; Zou ZW; Huang J; Ding Q
    Mol Med Rep; 2014 Oct; 10(4):1709-16. PubMed ID: 25109634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.
    Balbous A; Cortes U; Guilloteau K; Rivet P; Pinel B; Duchesne M; Godet J; Boissonnade O; Wager M; Bensadoun RJ; Chomel JC; Karayan-Tapon L
    BMC Cancer; 2016 Aug; 16():604. PubMed ID: 27495836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
    Zhu Y; Wen X; Zhao P
    Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors.
    Dok R; Kalev P; Van Limbergen EJ; Asbagh LA; Vázquez I; Hauben E; Sablina A; Nuyts S
    Cancer Res; 2014 Mar; 74(6):1739-51. PubMed ID: 24473065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ.
    Song L; McNeil EM; Ritchie AM; Astell KR; Gourley C; Melton DW
    BMC Cancer; 2017 Dec; 17(1):864. PubMed ID: 29254481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
    Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
    Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway.
    Liu Y; Liu Y; Jiao WP
    Bull Exp Biol Med; 2023 Feb; 174(4):489-496. PubMed ID: 36899199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer.
    Nguyen L; Dobiasch S; Schneider G; Schmid RM; Azimzadeh O; Kanev K; Buschmann D; Pfaffl MW; Bartzsch S; Schmid TE; Schilling D; Combs SE
    Radiother Oncol; 2021 Jun; 159():265-276. PubMed ID: 33839203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.
    Krumm A; Barckhausen C; Kücük P; Tomaszowski KH; Loquai C; Fahrer J; Krämer OH; Kaina B; Roos WP
    Cancer Res; 2016 May; 76(10):3067-77. PubMed ID: 26980768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.